Molecular Devices has several key strengths that differentiate it from its competitors. Firstly, it possesses a robust portfolio of advanced technologies, including high-throughput screening and imaging solutions that are tailored for drug discovery. Moreover, its strong focus on innovation ensures that it consistently develops cutting-edge instruments, coupled with exceptional software capabilities for data analysis. Furthermore, the company emphasizes customer support and engagement, providing users with comprehensive training and resources to maximize their product use.
Molecular Devices - Company Profile
All the data and insights you need on Molecular Devices in one report.
- • Save hours of research time and resources with our up-to-date Molecular Devices Strategy Report
- • Understand Molecular Devices's position in the market, performance, and strategic initiatives
- • Gain competitive edge and increase your chances of success
Molecular Devices Competitors
| Competitor | Headquarters | No. of Employees | Revenue | Entity Type |
|---|---|---|---|---|
Thermo Fisher Scientific | United States of America | 80,000+ | $39.2B | Public |
Agilent Technologies | United States of America | 16,500 | $5.7B | Public |
Waters Corporation | United States of America | 7,600 | $2.4B | Public |
PerkinElmer | United States of America | 14,000 | $3.1B | Public |
Bruker Corporation | United States of America | 7,500 | $2.0B | Public |
Eppendorf AG | Germany | 3,000 | $700M | Private |
Hudson Robotics | United States of America | 100 | $10M | Private |
QIAGEN N.V. | Netherlands | 5,000 | $1.5B | Public |
Bio-Rad Laboratories | United States of America | 8,000 | $2.5B | Public |
FISHER SCIENTIFIC | United States of America | 13,000 | $4.5B | Public |
Agilent | United States of America | 17,000 | $6.1B | Public |
Sartorius AG | Germany | 13,000 | $3.4B | Public |
MilliporeSigma | United States of America | 9,000 | $3.0B | Private |
Tecan Group | Switzerland | 1,600 | $520M | Public |
Hamilton Company | United States of America | 1,700 | $350M | Private |
Overview of Molecular Devices's competitor analysis
The molecular devices industry is characterized by a dynamic and competitive landscape, featuring major players like Thermo Fisher Scientific and Agilent Technologies, which offer a broad range of life sciences solutions. Public companies dominate the market, leveraging their substantial revenues and workforce to drive innovation and maintain market leadership. Additionally, private companies like Hudson Robotics and Hamilton Company continue to adapt to niche markets, providing specialized equipment and technology. Competitive advantages often arise from strong research and development capabilities, customer relationships, and proprietary technologies.
What are Molecular Devices's key strengths compared to competitors?
FAQs
Who are the main competitors of molecular-devices?
The main competitors of Molecular Devices include Thermo Fisher Scientific, PerkinElmer, and GE Healthcare. These companies also offer a range of products and services in the life sciences sector, focusing on areas like drug discovery, diagnostics, and research technologies.
Which company is the largest competitor of molecular-devices in terms of revenue?
The largest competitor of Molecular Devices is Thermo Fisher Scientific with a revenue exceeding $39 billion. In comparison, Molecular Devices generates approximately $300 million in revenue annually, making it a significant player, yet smaller than Thermo Fisher in terms of financial scale.
What are molecular-devices’s key strengths compared to competitors?
Molecular Devices distinguishes itself through innovative products, dedicated customer support, and extensive expertise in assay technology. Its focus on providing tailored solutions for biotechnology and pharmaceutical research enhances its attractiveness to clients. This unique blend of technology and service is a defining strength compared to its competitors.
Where can I find a detailed comparison of molecular-devices and its competitors?
You can find a detailed comparison of Molecular Devices and its competitors through our custom research services. For more information on this, visit Custom Research and learn about our Research Methodology to explore in-depth analyses.
Thermo Fisher Scientific
Headquarters:
United States of America
No. of Employees:
80,000+
Revenue:
$39.2B
Entity Type:
Public
Agilent Technologies
Headquarters:
United States of America
No. of Employees:
16,500
Revenue:
$5.7B
Entity Type:
Public
Waters Corporation
Headquarters:
United States of America
No. of Employees:
7,600
Revenue:
$2.4B
Entity Type:
Public
PerkinElmer
Headquarters:
United States of America
No. of Employees:
14,000
Revenue:
$3.1B
Entity Type:
Public
Bruker Corporation
Headquarters:
United States of America
No. of Employees:
7,500
Revenue:
$2.0B
Entity Type:
Public
Eppendorf AG
Headquarters:
Germany
No. of Employees:
3,000
Revenue:
$700M
Entity Type:
Private
Hudson Robotics
Headquarters:
United States of America
No. of Employees:
100
Revenue:
$10M
Entity Type:
Private
QIAGEN N.V.
Headquarters:
Netherlands
No. of Employees:
5,000
Revenue:
$1.5B
Entity Type:
Public
Bio-Rad Laboratories
Headquarters:
United States of America
No. of Employees:
8,000
Revenue:
$2.5B
Entity Type:
Public
FISHER SCIENTIFIC
Headquarters:
United States of America
No. of Employees:
13,000
Revenue:
$4.5B
Entity Type:
Public
Agilent
Headquarters:
United States of America
No. of Employees:
17,000
Revenue:
$6.1B
Entity Type:
Public
Sartorius AG
Headquarters:
Germany
No. of Employees:
13,000
Revenue:
$3.4B
Entity Type:
Public
MilliporeSigma
Headquarters:
United States of America
No. of Employees:
9,000
Revenue:
$3.0B
Entity Type:
Private
Tecan Group
Headquarters:
Switzerland
No. of Employees:
1,600
Revenue:
$520M
Entity Type:
Public
Hamilton Company
Headquarters:
United States of America
No. of Employees:
1,700
Revenue:
$350M
Entity Type:
Private
Overview of Molecular Devices competitor analysis
The molecular devices industry is characterized by a dynamic and competitive landscape, featuring major players like Thermo Fisher Scientific and Agilent Technologies, which offer a broad range of life sciences solutions. Public companies dominate the market, leveraging their substantial revenues and workforce to drive innovation and maintain market leadership. Additionally, private companies like Hudson Robotics and Hamilton Company continue to adapt to niche markets, providing specialized equipment and technology. Competitive advantages often arise from strong research and development capabilities, customer relationships, and proprietary technologies.